Aug 31, 2022
Four packs of Duloxetine E/C Caps have shown repeating cycles of shortages, price variation sand concessions. These sorts of cycles are seen in about 80% of generic products, and can result in severe shortages which affect patients, pharmacies, clinicians and tax...
Aug 30, 2022
In light of the increases to the rebates that branded and brand-generic manufacturers have to return to the NHS under the VPAS voluntary and statutory schemes, with forecast rebates of 25% in 2023 we thought it worth having a look at the amount of effort each type of...
Aug 24, 2022
At Wavedata we have always believed that product complexity and manufacturing cost was the limiting factor on how quickly prices would fall after generic launch. However, is this correct? To clarify this Wavedata looked at 414 solid dose, combined, liquids, devices...
Aug 22, 2022
Comparing Retail Market Prices with the English Drug Tariff. Wavedata have been collecting the prices offered to or paid by pharmacies since 2000, so we thought we’d do a comparison between the generic prices we collected in August 2022 and the English Drug Tariff. We...
Aug 19, 2022
The companies making and selling branded products need to understand how well their efforts are working to convince GPs to prescribe their brands. The graphic below shows a number of branded generics, however changes in the way they are reimbursed (VPAS) means that...
Aug 17, 2022
The companies making and selling branded generics do help to save the NHS money, though in a rather roundabout way. They could simply launch generics and compete with each other for market share. However, having their own brand names allows them to improve the quality...
